The World Health Organization (WHO) has recommended the new malaria vaccine R21/Matrix-M for the prevention of malaria in children.

The approval of the R21 vaccine is expected to result in sufficient vaccine supply to benefit all children living in areas where malaria is a public health risk.

The R21 vaccine is the second malaria vaccine to be recommended by WHO. In 2021, WHO recommended the RTS,S/AS01 vaccine. Both vaccines are safe and effective in preventing malaria in children.

मलेरिया हर साल 600,000 से अधिक लोगों को मारता है। 2021 में, WHO अफ्रीकी क्षेत्र में 95% मामलों के साथ मलेरिया के अनुमानित 247 मिलियन मामले थे। 5 वर्ष से कम आयु के बच्चे मलेरिया से प्रभावित सबसे कमजोर समूह हैं।

Malaria vaccines have taken decades to develop due to the complicated structure of the malaria parasite. Earlier this year, Ghana was the first country to approve the R21 vaccine.

WHO: WHO recommends R21/Matrix-M vaccine for malaria prevention